{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:29:00Z","timestamp":1786325340662,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471269"],"award-info":[{"award-number":["82471269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071420"],"award-info":[{"award-number":["82071420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011407","name":"Nanjing University of Science and Technology Key Laboratory of Jiangsu Province for Chemical Pollution Control and Resources Reuse","doi-asserted-by":"publisher","award":["ZDXK202217"],"award-info":[{"award-number":["ZDXK202217"]}],"id":[{"id":"10.13039\/501100011407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117089","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:54:20Z","timestamp":1782856460000},"page":"117089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GBA mutation exacerbates \u03b1-synuclein pathology with involvement of ROS and p38 MAPK signaling in Parkinson's disease"],"prefix":"10.1016","volume":"186","author":[{"given":"Hong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.intimp.2026.117089_bb0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"9996","key":"10.1016\/j.intimp.2026.117089_bb0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2026.117089_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117089_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-017-0780-8","article-title":"New genes causing hereditary Parkinson's disease or parkinsonism","volume":"17","author":"Puschmann","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.intimp.2026.117089_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.681369","article-title":"Targeting of lysosomal pathway genes for Parkinson's disease modification: insights from cellular and animal models","volume":"12","author":"Abe","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2026.117089_bb0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.conb.2021.11.004","article-title":"GBA mutations, glucosylceramide and Parkinson's disease","volume":"72","author":"Milenkovic","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41531-024-00756-5","article-title":"GBA-AAV mitigates sleep disruptions and motor deficits in mice with REM sleep behavior disorder","volume":"10","author":"Chen","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-020-00226-x","article-title":"Cross-talks among GBA mutations, glucocerebrosidase, and alpha-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review","volume":"10","author":"Behl","year":"2021","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.intimp.2026.117089_bb0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","article-title":"Increased incidence of Parkinson disease among relatives of patients with Gaucher disease","volume":"36","author":"Halperin","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.intimp.2026.117089_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-015-0010-2","article-title":"Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies","volume":"10","author":"Chiasserini","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.intimp.2026.117089_bb0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in parkinson's disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.intimp.2026.117089_bb0065","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"Alpha-synuclein misfolding and aggregation: implications in Parkinson's disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"issue":"7","key":"10.1016\/j.intimp.2026.117089_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133863","article-title":"Did alpha-synuclein and glucocerebrosidase coevolve? Implications for Parkinson's disease","volume":"10","author":"Gruschus","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-019-0336-2","article-title":"Glucocerebrosidase and its relevance to Parkinson disease","volume":"14","author":"Do","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"27","key":"10.1016\/j.intimp.2026.117089_bb0080","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.intimp.2026.117089_bb0085","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Vogiatzi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117089_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-cellbio-111315-125125","article-title":"The lysosome as a regulatory hub","volume":"32","author":"Perera","year":"2016","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117089_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","article-title":"The mechanisms and roles of selective autophagy in mammals","volume":"24","author":"Vargas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117089_bb0100","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.biocel.2004.05.009","article-title":"LC3 conjugation system in mammalian autophagy","volume":"36","author":"Tanida","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117089_bb0105","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.intimp.2026.117089_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10545-010-9075-9","article-title":"Pathophysiology of neuropathic lysosomal storage disorders","volume":"33","author":"Bellettato","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"30","key":"10.1016\/j.intimp.2026.117089_bb0115","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","article-title":"Cysteine cathepsins are essential in lysosomal degradation of alpha-synuclein","volume":"112","author":"McGlinchey","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.intimp.2026.117089_bb0120","first-page":"199","article-title":"The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS","volume":"1","author":"Bachstetter","year":"2010","journal-title":"Aging Dis."},{"issue":"10","key":"10.1016\/j.intimp.2026.117089_bb0125","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.intimp.2026.117089_bb0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","article-title":"ER stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson\u2019s iPSC-derived dopamine neurons","volume":"6","author":"Fernandes","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112986","article-title":"The two-domain architecture of LAMP2A regulates its interaction with Hsc70","volume":"411","author":"Ikami","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.117089_bb0140","doi-asserted-by":"crossref","first-page":"eabm1140","DOI":"10.1126\/sciadv.abm1140","article-title":"LAMP2A regulates the loading of proteins into exosomes","volume":"8","author":"Ferreira","year":"2022","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.intimp.2026.117089_bb0145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Mizushima","year":"2007","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0150","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1038\/s41598-019-46657-z","article-title":"LC3-positive structures are prominent in autophagy-deficient cells","volume":"9","author":"Runwal","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.117089_bb0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"40","key":"10.1016\/j.intimp.2026.117089_bb0160","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.117089_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12948","article-title":"Melatonin MT1 receptors regulate the Sirt1\/Nrf2\/Ho-1\/Gpx4 pathway to prevent \u03b1-synuclein-induced ferroptosis in Parkinson's disease","volume":"76","author":"Lv","year":"2024","journal-title":"J. Pineal Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.117089_bb0170","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.intimp.2026.117089_bb0175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2026.117089_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128346","article-title":"Cadmium induced BEAS-2B cells apoptosis and mitochondria damage via MAPK signaling pathway","volume":"263","author":"Cao","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.intimp.2026.117089_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102452","article-title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization","volume":"56","author":"Liu","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M110.150433","article-title":"X-ray and biochemical analysis of N370S mutant human acid beta-glucosidase","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2026.117089_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081261","article-title":"GBA variants and Parkinson disease: mechanisms and treatments","volume":"11","author":"Smith","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00441-017-2704-y","article-title":"Molecular mechanisms of alpha-synuclein and GBA1 in Parkinson's disease","volume":"373","author":"Stojkovska","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117089_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mthe.2002.0650","article-title":"Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model","volume":"6","author":"Marshall","year":"2002","journal-title":"Mol. Ther."},{"issue":"28","key":"10.1016\/j.intimp.2026.117089_bb0210","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces alpha-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci."},{"issue":"29","key":"10.1016\/j.intimp.2026.117089_bb0215","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","article-title":"Activation of beta-glucocerebrosidase reduces pathological alpha-synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons","volume":"36","author":"Mazzulli","year":"2016","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117089_bb0220","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1073\/pnas.1221046110","article-title":"Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"52","key":"10.1016\/j.intimp.2026.117089_bb0225","doi-asserted-by":"crossref","first-page":"21200","DOI":"10.1073\/pnas.1119181109","article-title":"Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease","volume":"108","author":"Lu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2026.117089_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2011.02.001","article-title":"There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells","volume":"12","author":"Brown","year":"2012","journal-title":"Mitochondrion"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2026.117089_bb0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1089\/ars.2006.8.600","article-title":"Apoptosis and aging: role of p66Shc redox protein","volume":"8","author":"Migliaccio","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.intimp.2026.117089_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/135100005X70170","article-title":"Lysosomal ROS formation","volume":"10","author":"Nohl","year":"2005","journal-title":"Redox Rep."},{"issue":"9\u201310","key":"10.1016\/j.intimp.2026.117089_bb0245","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1089\/ars.2006.8.1775","article-title":"Reactive oxygen species-induced activation of the MAP kinase signaling pathways","volume":"8","author":"McCubrey","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.intimp.2026.117089_bb0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.intimp.2026.117089_bb0255","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1074\/jbc.275.10.7395","volume":"275","author":"Lali","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117089_bb0260","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease","volume":"2012","author":"Correa","year":"2012","journal-title":"J. Signal Transduct."},{"issue":"2","key":"10.1016\/j.intimp.2026.117089_bb0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease","volume":"51","author":"Sanders","year":"2013","journal-title":"Blood Cells Mol. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:45:20Z","timestamp":1786322720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S1567576926009355"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117089","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GBA mutation exacerbates \u03b1-synuclein pathology with involvement of ROS and p38 MAPK signaling in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117089"}}